Healthcare -
Biotechnology - NASDAQ - US
$ 2.405
-2.63 %
$ 366 M
Market Cap
-26.72
P/E
HRTX - CASH FROM OPERATIONS
Cash from Operations HRTX - Heron Therapeutics, Inc.
-58.8 M
LAST VALUE
46.23%
2 YEAR CAGR
21.06%
5 YEAR CAGR
-3.73%
10 YEAR CAGR